Keyphrases
Cyclooxygenase-2
100%
Pioglitazone
100%
Cytosolic Phospholipase A2 (cPLA2)
100%
Myocardial Infarct Size
100%
Infarct Size
36%
Knock-in Mouse Model
27%
LoxP
27%
Cell Death
18%
Hypoxia-reoxygenation
18%
Adult Cardiomyocytes
18%
Cre Mice
18%
AKT1
18%
Cardiomyocytes
9%
Reperfusion
9%
Cyclooxygenase-2 Expression
9%
Hypoxia
9%
Two-level
9%
Deoxygenation
9%
Coronary Occlusion
9%
Reduced Cell
9%
PPAR Activation
9%
Cre-loxP
9%
PPAR Agonists
9%
PPAR Gene
9%
Area at Risk
9%
Hypoxia Injury
9%
Blue Dye
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 2
100%
Heart Infarction
100%
Peroxisome Proliferator Activated Receptor
100%
Pioglitazone
100%
Cytosolic Phospholipase A2
100%
Hypoxia
25%
Phospholipase A
25%
Infarction
25%
Knockout Mouse
18%
Tamoxifen
12%
PPAR Agonist
6%
Coronary Artery Occlusion
6%
Biochemistry, Genetics and Molecular Biology
Cyclooxygenase
100%
Peroxisome Proliferator-Activated Receptor
100%
Pioglitazone
100%
Protein Kinase B
100%
Phospholipase A
25%
Reoxygenation
25%
Knockout Mouse
18%
Cardiac Muscle Cell
18%
Cell Death
12%
Reperfusion
6%
PPAR Agonist
6%
Immunology and Microbiology
Cyclooxygenase
100%
Reoxygenation
80%
Knockout Mouse
60%
Cardiac Muscle Cell
60%
Cell Death
40%
Agonist
20%
Reperfusion
20%
In Vitro
20%
Pretreatment
20%